Search Results - "Cançado, Eduardo Luiz R"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Follow-up of Pregnant Women With Autoimmune Hepatitis: The Disease Behavior Along With Maternal and Fetal Outcomes by Terrabuio, Debora Raquel B, Abrantes-Lemos, Clarice Pires, Carrilho, Flair José, Cançado, Eduardo Luiz R

    Published in Journal of clinical gastroenterology (01-04-2009)
    “…GOALSTo assess maternal and fetal outcomes and clinical management of pregnancy in patients with autoimmune hepatitis (AIH). BACKGROUNDThere is a paucity of…”
    Get full text
    Journal Article
  2. 2

    Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis by Dellavance, Alessandra, Cançado, Eduardo Luiz R., Abrantes-Lemos, Clarice Pires, Harriz, Michelle, Marvulle, Valdecir, Andrade, Luis Eduardo C.

    Published in Hepatology international (01-06-2013)
    “…Objective To compare autoantibody features in patients with primary biliary cirrhosis (PBC) and individuals presenting antimitochondria antibodies (AMAs) but…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study by Mucenic, Marcos, Mello, Evandro Sobroza de, Cançado, Eduardo Luiz R

    Published in Arquivos de gastroenterologia (01-12-2005)
    “…Due to the risks related to long-term treatment with prednisone and azathioprine, most clinicians try to withdraw these drugs when patients with autoimmune…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of γ-glutamyl transpeptidase by Cançado, Eduardo Luiz R, Cubero Leitão, Regina Maria, Carrilho, Flair José, Atı́lio Laudanna, Antônio

    Published in The American journal of gastroenterology (01-09-1998)
    “…Objective: Rifampicin is an effective drug against pruritus in intrahepatic cholestasis. However, there is no specific hepatic disease in which its use could…”
    Get full text
    Journal Article
  7. 7

    Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of γ-glutamyl transpeptidase by CANCADO, E. L. R, CUBERO LEITAO, R. M, CARRILHO, F. J, LAUDANNA, A. A

    Published in The American journal of gastroenterology (01-09-1998)
    “…Rifampicin is an effective drug against pruritus in intrahepatic cholestasis. However, there is no specific hepatic disease in which its use could cause…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study Cloroquina para manutenção da remissão da hepatite auto-imune: resultado de estudo piloto by Marcos Mucenic, Evandro Sobroza de Mello, Eduardo Luiz R. Cançado

    Published in Arquivos de gastroenterologia (01-12-2005)
    “…BACKGROUND: Due to the risks related to long-term treatment with prednisone and azathioprine, most clinicians try to withdraw these drugs when patients with…”
    Get full text
    Journal Article
  9. 9

    Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture by Cancado, EL, Vilas-Boas, LS, Abrantes-Lemos, CP, Novo, NF, Porta, G, Da Silva, LC, Laudanna, AA

    Published in Hepatology (Baltimore, Md.) (01-05-1996)
    “…In autoimmune hepatitis (AIH), the smooth-muscle antibody is specific for polymerized actin. Detection of antiactin antibody (AAA) has been hampered by…”
    Get full text
    Journal Article
  10. 10

    Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of g-glutamyl transpeptidase by Cancado, Eduardo Luiz R, Cubero Leitao, Regina Maria, Carrilho, Flair Jose, Atilio Laudanna, Antonio

    Published in The American journal of gastroenterology (01-09-1998)
    “…Objective:Rifampicin is an effective drug against pruritus in intrahepatic cholestasis. However, there is no specific hepatic disease in which its use could…”
    Get full text
    Journal Article